From: The use of continuous data versus binary data in MTC models: A case study in rheumatoid arthritis
Trial | Arm | N | HAQ20 | HAQ50 | ACRcont (SD) |
---|---|---|---|---|---|
Weinblatt et al. [31] | P+ | 62 | 30 | 12 | 0.08 (0.22) |
 | Ada+ | 69 | 45 | 24 | 0.35 (0.20) |
 | Ada+ | 67 | 47 | 26 | 0.46 (0.22) |
 | Ada+ | 73 | 52 | 26 | 0.42 (0.21) |
Keystone et al. [32] | P+ | 200 | 95 | 32 | 0.13 (0.22) |
 | Ada+ | 212 | 141 | 81 | 0.42 (0.21) |
 | Ada+ | 207 | 154 | 82 | 0.41 (0.21) |
Van de Putte et al. [33] | P | 110 | 29 | 4 | 0.09 (0.20) |
 | Ada | 112 | 47 | 16 | 0.31 (0.19) |
 | Ada | 106 | 60 | 19 | 0.30 (0.19) |
 | Ada | 103 | 57 | 20 | 0.38 (0.22) |
 | Ada | 113 | 60 | 21 | 0.33 (0.20) |
Miyasaka [34] | P | 87 | 23 | 8 | 0.07 (0.17) |
 | Ada | 87 | 37 | 10 | 0.28 (0.19) |
 | Ada | 91 | 39 | 16 | 0.33 (0.20) |
 | Ada | 87 | 48 | 18 | 0.37 (0.21) |
Kim et al. [35] | P+ | 63 | 28 | 10 | 0.18 (0.27) |
 | Ada+ | 65 | 43 | 24 | 0.42 (0.22) |
Maini et al. [36] | P+ | 88 | 40 | 9 | 0.09 (0.19) |
 | Inf+ | 86 | 40 | 12 | 0.35 (0.19) |
 | Inf+ | 86 | 54 | 19 | 0.36 (0.20) |
 | Inf+ | 87 | 52 | 23 | 0.38 (0.21) |
 | Inf+ | 81 | 48 | 20 | 0.37 (0.19) |
Westhoven et al. [37] | P+ | 363 | - | - | 0.12 (0.23) |
 | Inf+ | 360 | - | - | 0.37 (0.20) |
 | Inf+ | 361 | - | - | 0.38 (0.21) |
Zhang et al. [38] | P+ | 86 | 52 | 28 | 0.27 (0.31) |
 | Inf+ | 87 | 61 | 39 | 0.46 (0.20) |
Schiff et al. [39] | P+ | 110 | - | - | 0.22 (0.29) |
 | Inf+ | 165 | - | - | 0.41 (0.22) |
Moreland et al. [40] | P | 80 | 25 | 8 | 0.06 (0.16) |
 | Eta | 76 | 47 | 26 | 0.34 (0.19) |
 | Eta | 78 | 53 | 31 | 0.40 (0.21) |
Weinblatt et al. [41] | P+ | 30 | 16 | 8 | 0.10 (0.17) |
 | Eta+ | 59 | 45 | 29 | 0.43 (0.19) |
Keystone et al. [42] | P+ | 133 | 49 | 13 | 0.14 (0.25) |
 | Gol | 133 | 56 | 29 | 0.30 (0.20) |
 | Gol+ | 89 | 51 | 24 | 0.40 (0.22) |
 | Gol+ | 89 | 60 | 31 | 0.39 (0.21) |
Kay et al. [43] | P+ | 35 | - | - | 0.14 (0.20) |
 | Gol+ | 35 | - | - | 0.39 (0.20) |
 | Gol+ | 34 | - | - | 0.38 (0.21) |
Keystone et al. [44] | P+ | 199 | 83 | 35 | 0.07 (0.20) |
 | Cert+ | 393 | 263 | 146 | 0.40 (0.22) |
 | Cert+ | 390 | 249 | 137 | 0.41 (0.22) |
Smolen et al. [45] | P+ | 127 | 46 | 10 | 0.04 (0.14) |
 | Cert+ | 246 | 163 | 66 | 0.38 (0.21) |
 | Cert+ | 246 | 155 | 67 | 0.38 (0.20) |
Fleischmann et al. [46] | P | 109 | 19 | 2 | 0.04 (0.14) |
 | Cert | 111 | 60 | 34 | 0.33 (0.19) |